期刊文献+

异氟烷预处理对心肌缺血再灌注损伤大鼠心肌p38丝裂原活化蛋白激酶水平的影响 被引量:3

Effects of isoflurane preconditioning on p38 MAPK in a rat model of myocardial ischemia-reperfusion
下载PDF
导出
摘要 目的探讨异氟烷预处理对心肌缺血再灌注大鼠心肌p38丝裂原活化蛋白激酶(p38 mitogen-activatedprotein kinase,p38 MAPK)水平的影响。方法雄性Wistar大鼠90只,体重270~390 g。腹腔注射硫代仲丁巴比妥钠150 mg/kg麻醉后,阻断左冠状动脉前降支30 min,再灌注2 h,建立心肌缺血再灌注损伤模型。取60只大鼠,随机分为6组(n=10),于缺血前CON组静脉注射0.9%生理盐水;SB组经3 min静脉注射p38 MAPK抑制剂SB203580 1.5 mg/kg;DMSO组经3 min静脉注射SB203580溶剂DMSO 0.2 mL;ISO组吸入1.0 MAC异氟烷30 min后停止吸入15 min;SB+ISO组和ISO+SB组分别在吸入异氟烷前即刻和吸入异氟烷后即刻静脉注射SB203580 1.5 mg/kg。再灌注2 h后采用氯化硝基四氮唑蓝染色法测定心肌梗死面积。取剩余的30只大鼠,随机分为5组(n=6),CON组、SB组、ISO组、SB+ISO组和ISO+SB组所有处理同前。缺血前即刻、再灌注后2 h即刻取心肌标本,采用Western blot法测定p38 MAPK的表达水平。结果与CON组比较,SB组、ISO组、SB+ISO组和ISO+SB组心肌梗死面积降低(P<0.05)。再灌注后的CON组和ISO组p38 MAPK水平高于缺血前CON组(P<0.05)。结论异氟烷预处理和p38 MAPK抑制剂SB203580对心肌有保护作用,但p38 MAPK未参与异氟烷预处理减轻大鼠心肌缺血再灌注损伤的机制。 Objective To investigate the effects of isoflurane preconditioning on the expression of p38 mitogen-activated protein kinase(p38 MAPK) in myocardium in a rat model of myocardial ischemia-reperfusion(I/R). Methods Ninety male Wistar rats weighing 270-390 g were anesthetized with intraperitoneal thiobutabarbital 150 mg/kg,tracheostomized and mechanically ventilated.I/R were produced by reversible occlusion of left anterior descending branch(LAD) of coronary artery for 30 min followed by 2-hour reperfusion.Then,sixty animals were randomly divided into 6 groups(n=10 for each):(1) control group received intravenous normal saline(NS) before I/R;(2) SB group received SB203580(p38 MAPK inhibitor) 1.5 mg/kg iv before I/R;(3) DMSO group received DMSO(the SB203580 solvent) 0.2 mL before I/R;(4) ISO group inhaled 1.0 MAC isoflurane for 30 min followed by 15 min wash-out before I/R;(5) SB+ISO group and(6) ISO+SB group received SB 1.5 mg/kg before and after 30 min 1.0 MAC isoflurane inhalation.At the end of 2-hour reperfusion,the size of myocardial infarct was determined using triphenyl tetrazolium chloride staining.Another 30 animals were randomly divided into 5 groups(n=6 for each): control group,SB group,ISO group,SB+ISO group and ISO+SB group.Before occlusion of LAD and at the end of 2-hour reperfusion,myocardial specimens were obtained for determination of expression of p38 MAPK protein in myocardium(Western blot). Results SB group,ISO group,SB+ISO group and ISO+SB group significantly reduced infarct size.The expression of p38 MAPK protein was up-regulated in CON group and ISO group after 2-hour reperfusion as compared to the CON group before occlusion of LAD.Conclusions Isoflurane preconditioning and p38 MAPK inhibitor SB203580 can protect myocardium against I/R injury,but p38 MAPK may not be involved in the mechanism of isoflurane preconditioning.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2010年第3期269-273,共5页 Fudan University Journal of Medical Sciences
基金 国家自然科学基金(30872453) 江苏省自然科学基金(BK2008166) 江苏省高校自然科学基础研究面上项目(08KJD32005) 苏州市第13批科技发展计划(社会发展及医药)项目(2008-11) 苏州大学附属第二医院留学回国人员启动基金项目(2006-1)
关键词 异氟烷 缺血预处理 心肌再灌注损伤 P38丝裂原活化蛋白激酶 心肌 isoflurane ischemic preconditioning myocardial reperfusion injury p38 mitogen-activated protein kinase myocardium
  • 相关文献

参考文献13

  • 1Riess ML,Costa AD,Carlson R Jr,et al.Differential increase of mitochondrial matrix volume by sevoflurane in isolated cardiac mitochondria[J].Anesth Analg,2008,106(4):1 049-1 055.
  • 2覃琴,王琛,朱江,刘霞,姜琳,谢红.七氟醚预处理中核因子-κB的激活对大鼠心肌缺血/再灌注损伤的保护作用[J].国际麻醉学与复苏杂志,2008,29(3):197-200. 被引量:10
  • 3刘霞,王琛,谢红,覃琴,吴雪梅,乔世刚,刘虹.七氟烷预处理对心肌缺血/再灌注损伤大鼠心肌NF—κBp50活性表达的影响[J].国际麻醉学与复苏杂志,2009,30(2):112-115. 被引量:6
  • 4王琛,谢红,覃琴,朱江,徐府奇.异氟醚预处理对心肌缺血再灌注大鼠心肌ERK1/ERK2、HIF-1α和VEGF水平的影响[J].中华麻醉学杂志,2007,27(10):886-889. 被引量:4
  • 5Roesslein M,Frick M,Auwaerter V,et al.Sevoflurane-mediated activation of p38-mitogen-activated stresskinase is independent of apoptosis in Jurkat T-cells[J].Anesth Analg,2008,106(4):1 150-1 160.
  • 6Lochner A,Marais E,Genade S,et al.Protection of the ischaemic heart:investigations into the phenomenon of ischaemic preconditioning[J].Cardiovasc J Afr,2009,20(1):43-51.
  • 7Barancik M,Htun P,Strohm C,et al.Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death[J].J Cardiovasc Pharmacol,2000,35(3):474-483.
  • 8Nakano A,Baines CP,Kim SO,et al.Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart:evidence for involvement of p38 MAPK[J].Circ Res,2000,86(2):144-151.
  • 9Vohra HA,Galinanes M.Myocardial preconditioning against ischemia-induced apoptosis and necrosis in man[J].J Surg Res,2006,134(1):138-144.
  • 10Pavel S,Rafaela DS,Eliana L,et al.Trigger-dependent Gene Expression Profiles in cardiac preconditioning:evidence for distinct genetic programs in ischemic and anesthetic preconditioning[J].Anesthesiology,2004,100(3):474-488.

二级参考文献43

  • 1Tanaka K, Ludwig LM, Kersten JR, et al. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology, 2004, 100: 707-721.
  • 2De Hert SG, Turani F, Mathur S, et al. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg, 2005, 100: 1584-1593.
  • 3Venkatapuram S, Wang C, Krolikowski GJ, et al. Inhibition of apoptotic protein P53 lowers the threshold of isoflurane - induced cardioprotection during early reperfusion in rabbits. Anesth Analg, 2006, 103: 1400-1405.
  • 4Wang C, Neff DA, Krolikowski GJ, et al. The influence of B - cell lymphoma 2 protein, an antiapoptotic regulator of mitochondrial permeability transition, on isoflurane - induced and ischemic postconditioning in rabbits. Anesth Analg, 2006, 102: 1355-1360.
  • 5Morgan EN, Boyle EM Jr, Yun W, et al. An essential role for NF - κB in the cardioadaptive response to ischemia. Ann Thorac Surg, 1999, 68 : 377-382.
  • 6Valen G, Paulsson G, Vaage J. Induction of inflammatory mediators during reperfusion of the human heart. Ann Thorac Surg, 2001, 71 : 226-232.
  • 7Zhong CY, Zhou YM, Liu H. Nuclear factor - KB and anesthetic preconditioning during myocardial ischemia - reperfusion. Anesthesiology, 2004, 100: 540-546.
  • 8Ludwig LM, Weihrauch D, Kersten JR, et al. Protein kinase c translocation and src protein tyrosine kinase activation mediate isoflurane - induced preconditioning in vivo: potential downstream targets of mitochondfial adenosine tfiphosphate - sensitive potassium channels and re- active oxygen species. Anesthesiology, 2004, 100 : 532-539.
  • 9Riess ML, Stowe DF, Warltier DC. Cardiac pharmacological precondltioning with volatile anesthetics: from bench to bedside? Am J Physiol Heart Circ Physiol, 2004, 286: H1603-H1607.
  • 10Pratt PF, Wang C, Weihraueh D, et al. Cardioproteetion by volatile anesthetics: new applications for old drugs? Curr Opin Anaesthesiol, 2006, 19: 397-403.

共引文献11

同被引文献36

引证文献3

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部